Admission Date:  [**2168-7-7**]              Discharge Date:   [**2168-7-11**]  Date of Birth:  [**2120-9-9**]             Sex:   F  Service: NEUROSURGERY  Allergies: Penicillins / Methadone  Attending:[**First Name3 (LF) 1835**] Chief Complaint: left sided neglect, right sided weakness, dysarthria   Major Surgical or Invasive Procedure: [**2168-7-7**] L frontal craniotomy & tumor resection  History of Present Illness: Patient is a 47 year old woman with a history of metastatic melanoma with mets to the abdomen, brain, right tibia initially found via a shoulder lesion which was excised.
She underwent craniotomies for resection of Brain lesions with Dr [**Last Name (STitle) **] in [**2164**] and [**2165**], as well as cyberknife 3 times in [**2164**] and [**2165**] following her resections and then again in [**2166**].
Plan following that visit was for her to be discussed in brain [**Hospital 341**] Clinic on [**6-27**] with neuro-onc, rad-onc, and neurosurgery.
She was subsequently transferred to [**Hospital1 18**] for further management given these findings.
She was given Decadron 10mg IV x 1, as well as 2 units of RBCs and transferred here.
PET/CT scan revealed uptake in the right frontal bone, a 2 cm soft tissue mass near the  ascending colon and in the right tibia - Cyberknife radiosurgery to the skull lesion on [**2163-10-11**], followed by high-dose IL-2 therapy that was started on [**2163-11-14**].
- XRT to the right tibia over 5 fractions completed on [**2164-3-15**].
She took Chinese herbal medication until [**2165-3-5**].
She then received ipilimumab treatment from [**2165-3-6**] to [**2165-5-22**]  in a phase II protocol.
- resection by [**Name8 (MD) **], M.D.
She then had a left parietal craniotomy for resection of hemorrhagic  tumor by Dr. [**First Name8 (NamePattern2) **] [**Name (STitle) **] on [**2165-12-23**], followed by more Cyberknife radisurgery to a left cerebellar to 2200 cGy at 79% isodose line on [**2165-12-25**], and  another Cyberknife radiosurgery to a left medial frontal metastasis on [**2166-4-15**] to 2,200 cGy at 75% isodose line.
- underwent resection of the right proximal tibia and reconstruction with an oncologic hinged proximal tibia replacement prosthesis on [**2167-2-4**] by Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 4223**].
- status post EGD with biopsy on [**2167-7-16**] showing melanoma, and - received PD-1 antibody treatment from [**2168-1-27**] to [**2168-4-20**].
-  Left occipital craniotomy resection of brain mass [**2168-7-7**]  Social History: No tobacco, alcohol or drug use.
On right side is Intact to light touch  Toes downgoing bilaterally  Coordination: normal on finger-nose-finger with right upper extremity, does not complete on left side  Discharge exam: Gen; pleasant and cooperative neuro: AOX3 PERRL, EOM intact, face symmetric, motor [**5-28**] except for LLE secondary to known osteosarcoma, sensory intact to light tough, no clonus skin: incision intact, clean and dry with absorbable monocryl sutures in place.
Marked interval increase in size of the left frontal contrast-enhancing lesion, with an even larger interval increase in surrounding vasogenic edema in the bilateral frontal lobes, which now causes subfalcine herniation with 9-mm rightward shift of midline structures, as well as further effacement of the frontal [**Doctor Last Name 534**] of the left lateral ventricle.
MRI Brain [**2168-7-7**] No significant changes are identified since the most recent examination, unchanged left frontal heterogeneous enhancing lesion, similar pattern of enhancement surrounding the right frontal surgical cavity with ex vacuo dilatation of the ventricular frontal [**Doctor Last Name 534**].
CT Head [**2168-7-7**] Expected post craniotomy appearance.
Small amount of residual circumferential nodular enhancement around the left frontal  surgical bed.
Attention to these lesions should be paid in followup exams.
On [**7-9**], the patient was started on iron for a hematocrit of 24.
Her dose of Dexamethasone was weaned, and her Foley was discontinued.
Medications on Admission: citalopram, dexamethasone, keppra, lidocaine patch, ativan, ritalin, omeprazole, oxycodone   Discharge Medications: 1.
Acetaminophen 325-650 mg PO Q6H:PRN pain/temp/ha max 4g/24hrs 2.
Citalopram 20 mg PO DAILY 3.
Dexamethasone 2 mg po  bid Duration: 30 Days RX *dexamethasone 2 mg twice a day Disp #*60 Tablet Refills:*0 4.
Docusate Sodium 100 mg PO BID RX *Colace 100 mg twice a day Disp #*60 Capsule Refills:*0 5.
Ferrous Sulfate 325 mg PO DAILY 6.
Fluconazole 200 mg PO Q24H Duration: 4 Days RX *Diflucan 200 mg daily Disp #*4 Tablet Refills:*0 7.
Lorazepam 0.5 mg PO Q8H:PRN nausea, anxiety 8.
MethylPHENIDATE (Ritalin) 5 mg PO QAM 9.
Omeprazole 40 mg PO BID RX *omeprazole 40 mg twice a day Disp #*60 Capsule Refills:*0 10.
OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain RX *oxycodone 5 mg every four (4) hours Disp #*60 Tablet Refills:*0   Discharge Disposition: Home With Service  Facility: [**Hospital **] Hospice  Discharge Diagnosis: L frontal metastatic lesion pterygium post operative anemia constipation oral candidiasis  Discharge Condition: Mental Status: Clear and coherent.
Take your pain medicine as prescribed.
We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication.
You have been discharged on Keppra (Levetiracetam), you will not require blood work monitoring.
-  Please follow up with Ophthomolgy in [**7-1**] weeks for your Pterygium for evaluation and treatment.
